Identification of the Common Differentially Expressed Genes and Pathogenesis Between Neuropathic Pain and Aging

Overview

Journal Front Neurosci

Date 2022 Nov 7

PMID 36340779

Authors

Qingqing Ye

Zhensheng Huang

Weicheng Lu

Fang Yan

Weian Zeng

Jingdun Xie

Weiqiang Zhong

Affiliations

Soon will be listed here.

Abstract

Background: Neuropathic pain is a debilitating disease caused by damage or diseases of the somatosensory nervous system. Previous research has indicated potential associations between neuropathic pain and aging. However, the mechanisms by which they are interconnected remain unclear. In this study, we aim to identify the common differentially expressed genes (co-DEGs) between neuropathic pain and aging through integrated bioinformatics methods and further explore the underlying molecular mechanisms.

Methods: The microarray datasets GSE24982, GSE63442, and GSE63651 were downloaded from Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) and co-DEGs were first identified. Functional enrichment analyses, protein-protein Interaction (PPI) network, module construction and hub genes identification were performed. Immune infiltration analysis was conducted. Targeted transcription factors (TFs), microRNAs (miRNAs) and potential effective drug compounds for hub genes were also predicted.

Results: A total of 563 and 1,250 DEGs of neuropathic pain and aging were screened, respectively. 16 genes were further identified as co-DEGs. The functional analysis emphasizes the vital roles of the humoral immune response and complement and coagulation cascades in these two diseases. Cxcl14, Fblim1, RT1-Da, Serping1, Cfd, and Fcgr2b were identified as hub genes. Activated B cell, mast cell, activated dendritic cell, CD56 bright natural killer cell, effector memory CD8 + T cell, and type 2 T helper cell were significantly up-regulated in the pain and aging condition. Importantly, hub genes were found to correlate with the activated B cell, activated dendritic cell, Gamma delta T cell, central memory CD4 + T cell and mast cell in pain and aging diseases. Finally, Spic, miR-883-5p, and miR-363-5p et al. were predicted as the potential vital regulators for hub genes. Aldesleukin, Valziflocept, MGD-010, Cinryze, and Rhucin were the potential effective drugs in neuropathic pain and aging.

Conclusion: This study identified co-DEGs, revealed molecular mechanisms, demonstrated the immune microenvironment, and predicted the possible TFs, miRNAs regulation networks and new drug targets for neuropathic pain and aging, providing novel insights into further research.

Citing Articles

Locityper: targeted genotyping of complex polymorphic genes.

Prodanov T, Plender E, Seebohm G, Meuth S, Eichler E, Marschall T bioRxiv. 2025; .

PMID: 39990346 PMC: 11844405. DOI: 10.1101/2024.05.03.592358.

An in-depth understanding of the role and mechanisms of T cells in immune organ aging and age-related diseases.

Xu Y, Wang Z, Li S, Su J, Gao L, Ou J Sci China Life Sci. 2024; 68(2):328-353.

PMID: 39231902 DOI: 10.1007/s11427-024-2695-x.

Identification and validation of aging-related genes in neuropathic pain using bioinformatics.

Gao H, Dong G, Yao Y, Yang H Front Genet. 2024; 15:1430275.

PMID: 39113685 PMC: 11303200. DOI: 10.3389/fgene.2024.1430275.

Bioinformatics and systems biology approach to identify the pathogenetic link of neurological pain and major depressive disorder.

Hu J, Fu J, Cai Y, Chen S, Qu M, Zhang L Exp Biol Med (Maywood). 2024; 249:10129.

PMID: 38993198 PMC: 11236560. DOI: 10.3389/ebm.2024.10129.

Age-associated changes in multimodal pain perception.

Zhi Y, Zhang Y, Zhang M, Kong Y Age Ageing. 2024; 53(5).

PMID: 38776215 PMC: 11110914. DOI: 10.1093/ageing/afae107.

References

Finnerup N, Kuner R, Jensen T . Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev. 2020; 101(1):259-301. DOI: 10.1152/physrev.00045.2019. View

Zhang Y, Chi D . Overexpression of SIRT2 Alleviates Neuropathic Pain and Neuroinflammation Through Deacetylation of Transcription Factor Nuclear Factor-Kappa B. Inflammation. 2017; 41(2):569-578. DOI: 10.1007/s10753-017-0713-3. View

Finotello F, Trajanoski Z . Quantifying tumor-infiltrating immune cells from transcriptomics data. Cancer Immunol Immunother. 2018; 67(7):1031-1040. PMC: 6006237. DOI: 10.1007/s00262-018-2150-z. View

Childs B, Durik M, Baker D, van Deursen J . Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015; 21(12):1424-35. PMC: 4748967. DOI: 10.1038/nm.4000. View

Poh K, Yeo J, Stohler C, Ong W . Comprehensive gene expression profiling in the prefrontal cortex links immune activation and neutrophil infiltration to antinociception. J Neurosci. 2012; 32(1):35-45. PMC: 6621314. DOI: 10.1523/JNEUROSCI.2389-11.2012. View

Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch S, Croteau D . Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019; 15(10):565-581. DOI: 10.1038/s41582-019-0244-7. View

Peyrin-Biroulet L, Demarest S, Nirula A . Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies. Autoimmun Rev. 2018; 18(2):123-128. DOI: 10.1016/j.autrev.2018.07.014. View

Ji R, Chamessian A, Zhang Y . Pain regulation by non-neuronal cells and inflammation. Science. 2016; 354(6312):572-577. PMC: 5488328. DOI: 10.1126/science.aaf8924. View

Atzeni F, Nucera V, Masala I, Sarzi-Puttini P, Bonitta G . Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab. Pharmacol Res. 2019; 149:104402. DOI: 10.1016/j.phrs.2019.104402. View

10.

Morrison G, Van Langenberg D, Gibson S, Gibson P . Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort. Inflamm Bowel Dis. 2013; 19(6):1210-7. DOI: 10.1097/MIB.0b013e318280e729. View

11.

Almeida-Suhett C, Li Z, Marini A, Braga M, Eiden L . Temporal course of changes in gene expression suggests a cytokine-related mechanism for long-term hippocampal alteration after controlled cortical impact. J Neurotrauma. 2013; 31(7):683-90. PMC: 3961781. DOI: 10.1089/neu.2013.3029. View

12.

von Schack D, Agostino M, Murray B, Li Y, Reddy P, Chen J . Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain. PLoS One. 2011; 6(3):e17670. PMC: 3056716. DOI: 10.1371/journal.pone.0017670. View

13.

Cox A, Darbro B, Laxer R, Velez G, Bing X, Finer A . Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). PLoS One. 2017; 12(3):e0169687. PMC: 5354242. DOI: 10.1371/journal.pone.0169687. View

14.

Lopez-Otin C, Blasco M, Partridge L, Serrano M, Kroemer G . The hallmarks of aging. Cell. 2013; 153(6):1194-217. PMC: 3836174. DOI: 10.1016/j.cell.2013.05.039. View

15.

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z . clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021; 2(3):100141. PMC: 8454663. DOI: 10.1016/j.xinn.2021.100141. View

16.

Su K, Wu J, Edberg J, Li X, Ferguson P, Cooper G . A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol. 2004; 172(11):7186-91. DOI: 10.4049/jimmunol.172.11.7186. View

17.

Gompels M, Lock R . Cinryze (C1-inhibitor) for the treatment of hereditary angioedema. Expert Rev Clin Immunol. 2011; 7(5):569-73. DOI: 10.1586/eci.11.50. View

18.

Song P, Liu X, Zhao Z . Interleukin-2-induced antinociception in morphine-insensitive rats. Acta Pharmacol Sin. 2002; 23(11):981-4. View

19.

Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S . BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009; 10(11):R130. PMC: 3091323. DOI: 10.1186/gb-2009-10-11-r130. View

20.

Jensen T, Baron R, Haanpaa M, Kalso E, Loeser J, Rice A . A new definition of neuropathic pain. Pain. 2011; 152(10):2204-2205. DOI: 10.1016/j.pain.2011.06.017. View